These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9363677)

  • 1. p57KIP2 targeted disruption and Beckwith-Wiedemann syndrome: is the inhibitor just a contributor?
    Swanger WJ; Roberts JM
    Bioessays; 1997 Oct; 19(10):839-42. PubMed ID: 9363677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith-Wiedemann syndrome.
    Zhang P; Liégeois NJ; Wong C; Finegold M; Hou H; Thompson JC; Silverman A; Harper JW; DePinho RA; Elledge SJ
    Nature; 1997 May; 387(6629):151-8. PubMed ID: 9144284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disomy and disease resolved?
    Hastie N
    Nature; 1997 Oct; 389(6653):785, 787. PubMed ID: 9349803
    [No Abstract]   [Full Text] [Related]  

  • 4. An imprinted gene p57KIP2 is mutated in Beckwith-Wiedemann syndrome.
    Hatada I; Ohashi H; Fukushima Y; Kaneko Y; Inoue M; Komoto Y; Okada A; Ohishi S; Nabetani A; Morisaki H; Nakayama M; Niikawa N; Mukai T
    Nat Genet; 1996 Oct; 14(2):171-3. PubMed ID: 8841187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic imprinting of p57KIP2, a cyclin-dependent kinase inhibitor, in mouse.
    Hatada I; Mukai T
    Nat Genet; 1995 Oct; 11(2):204-6. PubMed ID: 7550351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transactivation of Igf2 in a mouse model of Beckwith-Wiedemann syndrome.
    Sun FL; Dean WL; Kelsey G; Allen ND; Reik W
    Nature; 1997 Oct; 389(6653):809-15. PubMed ID: 9349812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overgrowth syndromes and genomic imprinting: from mouse to man.
    Li M; Squire JA; Weksberg R
    Clin Genet; 1998 Mar; 53(3):165-70. PubMed ID: 9630066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased IGF-II protein affects p57kip2 expression in vivo and in vitro: implications for Beckwith-Wiedemann syndrome.
    Grandjean V; Smith J; Schofield PN; Ferguson-Smith AC
    Proc Natl Acad Sci U S A; 2000 May; 97(10):5279-84. PubMed ID: 10779549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of CDKN1C in Beckwith Wiedemann syndrome.
    Algar E; Brickell S; Deeble G; Amor D; Smith P
    Hum Mutat; 2000; 15(6):497-508. PubMed ID: 10862080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beckwith-Wiedemann syndrome: multiple molecular mechanisms.
    Enklaar T; Zabel BU; Prawitt D
    Expert Rev Mol Med; 2006 Jul; 8(17):1-19. PubMed ID: 16842655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IGF2 is parentally imprinted during human embryogenesis and in the Beckwith-Wiedemann syndrome.
    Ohlsson R; Nyström A; Pfeifer-Ohlsson S; Töhönen V; Hedborg F; Schofield P; Flam F; Ekström TJ
    Nat Genet; 1993 May; 4(1):94-7. PubMed ID: 8513333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p57(Kip2) knock-in mouse reveals CDK-independent contribution in the development of Beckwith-Wiedemann syndrome.
    Duquesnes N; Callot C; Jeannot P; Daburon V; Nakayama KI; Manenti S; Davy A; Besson A
    J Pathol; 2016 Jul; 239(3):250-61. PubMed ID: 27015986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cell type-specific IGF2 expression during early human development correlates to the pattern of overgrowth and neoplasia in the Beckwith-Wiedemann syndrome.
    Hedborg F; Holmgren L; Sandstedt B; Ohlsson R
    Am J Pathol; 1994 Oct; 145(4):802-17. PubMed ID: 7943172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The Wiedemann-Beckwith syndrome and a congenital cataract].
    Momtchilova M; Pelosse B; Laroche L; Vazquez MP
    J Fr Ophtalmol; 2001 May; 24(5):479-81. PubMed ID: 11397983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional analysis of the p57KIP2 gene mutation in Beckwith-Wiedemann syndrome.
    Bhuiyan ZA; Yatsuki H; Sasaguri T; Joh K; Soejima H; Zhu X; Hatada I; Morisaki H; Morisaki T; Mukai T
    Hum Genet; 1999 Mar; 104(3):205-10. PubMed ID: 10323243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wiedemann-Beckwith syndrome: genomic imprinting revisited.
    Weksberg R
    Am J Med Genet; 1994 Aug; 52(2):235-6. PubMed ID: 7802017
    [No Abstract]   [Full Text] [Related]  

  • 17. Beckwith-Wiedemann syndrome and the insulin-like growth factor-II gene. Does the genotype explain the phenotype?
    Witte DP; Bove KE
    Am J Pathol; 1994 Oct; 145(4):762-5. PubMed ID: 7943167
    [No Abstract]   [Full Text] [Related]  

  • 18. Insulin-like growth factor system on adrenocortical tumorigenesis.
    Ribeiro TC; Latronico AC
    Mol Cell Endocrinol; 2012 Mar; 351(1):96-100. PubMed ID: 22019903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The two-domain hypothesis in Beckwith-Wiedemann syndrome.
    Feinberg AP
    J Clin Invest; 2000 Sep; 106(6):739-40. PubMed ID: 10995782
    [No Abstract]   [Full Text] [Related]  

  • 20. Is p57KIP2 mutation a common mechanism for Beckwith-Wiedemann syndrome or somatic overgrowth?
    Okamoto K; Morison IM; Reeve AE; Tommerup N; Wiedemann HR; Friedrich U
    J Med Genet; 1998 Jan; 35(1):86. PubMed ID: 9475109
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.